Property and current clinical applications of mammal hyaluronidase

S-H Lv1, S-F Rong, B-G Cai

  • 1Master of Biochemistry, Department of Bioengineering, Shanghai Institute of Technology, China. qqli@sit.edu.cn.

Hyaluronidase (Hyal), which is related to mammalian diseases, is greatly significant for mammal. It is the major enzyme for degrading hyaluronan (HA), which is a linear high molecular polymer that is ubiquitous in mammalian extracellular matrix. Previous studies suggested that the levels of Hyals play significant roles in predicting, determining and curing many diseases. This review summarizes previous studies on the classification and biophysical and therapeutic applications of mammalian Hyals and focuses on the current medicinal and clinical applications of Hyals.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
7.7K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.5K